1. Home
  2. RANI vs PRE Comparison

RANI vs PRE Comparison

Compare RANI & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$1.40

Market Cap

134.6M

Sector

Health Care

ML Signal

HOLD

Logo Prenetics Global Limited

PRE

Prenetics Global Limited

HOLD

Current Price

$16.88

Market Cap

131.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RANI
PRE
Founded
2012
2014
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
134.6M
131.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
RANI
PRE
Price
$1.40
$16.88
Analyst Decision
Strong Buy
Buy
Analyst Count
6
1
Target Price
$8.67
$32.00
AVG Volume (30 Days)
2.6M
141.5K
Earning Date
11-06-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,200,000.00
$77,079,000.00
Revenue This Year
$414.59
$219.28
Revenue Next Year
$30.15
$124.38
P/E Ratio
N/A
N/A
Revenue Growth
N/A
201.54
52 Week Low
$0.39
$3.10
52 Week High
$3.87
$18.48

Technical Indicators

Market Signals
Indicator
RANI
PRE
Relative Strength Index (RSI) 42.10 57.43
Support Level $1.40 $16.17
Resistance Level $1.53 $18.48
Average True Range (ATR) 0.11 1.24
MACD -0.00 0.16
Stochastic Oscillator 15.00 60.49

Price Performance

Historical Comparison
RANI
PRE

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

About PRE Prenetics Global Limited

Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.

Share on Social Networks: